Cargando…
The effect of chronic kidney disease on CYP2B expression and activity in male Wistar rats
Chronic kidney disease (CKD) is characterized by progressive reduction in kidney function over time. CKD affects greater than 10% of the population and its incidence is on the rise due to the growing prevalence of its risk factors. Previous studies demonstrated CKD alters nonrenal clearance of drugs...
Autores principales: | Kucey, Andrew S., Velenosi, Thomas J., Tonial, Nicholas C., Tieu, Alvin, RaoPeters, Adrien A. E., Urquhart, Brad L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484215/ https://www.ncbi.nlm.nih.gov/pubmed/31049204 http://dx.doi.org/10.1002/prp2.475 |
Ejemplares similares
-
Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120
por: Velenosi, Thomas J., et al.
Publicado: (2016) -
Untargeted metabolomics reveals N, N, N-trimethyl-L-alanyl-L-proline betaine (TMAP) as a novel biomarker of kidney function
por: Velenosi, Thomas J., et al.
Publicado: (2019) -
Coffee inhibition of CYP3A4 in vitro was not translated to a grapefruit‐like pharmacokinetic interaction clinically
por: Dresser, George K., et al.
Publicado: (2017) -
Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets
por: Lim, Yong Jin, et al.
Publicado: (2021) -
VDR, CYP2R1 and CYP27B1 Genes Are Differentially Expressed in Male`s and Females Tissues of Wistar Rats
por: Oczkowicz, Maria, et al.
Publicado: (2021)